IQ4I Research & Consultancy published a new report on “Cell Analysis Global Market – Forecast To 2029”



Cell analysis is important for cell health, proliferation, function, and death by using various technologies such as PCR, Sequencing, Microfluidics, Spectrometry, Microscopes, High content analysis and others. Continuous advancements in technologies significantly revealed the heterogeneity, which will further enhance the cell analysis application.

Press Release

Amazon Music Disney Promo

Cell analysis encompasses a wide range of activities that help in understanding and predicting the dynamics that influence cell function, proliferation, growth and death. This is enabled through analysis of cell signaling mechanisms, elucidation of molecular function, study of cell behavior, and correlating to multiple events with cell morphology, changes in biochemical constituents and cell health. Cell analysis is gaining importance in various fields of applications such as drug discovery, diagnosis of infectious disease, cancer, genetic, neural, cardiac and others. Live-cell imaging, single-cell analysis, single cell spatial analysis, mass cytometry and high content screening (HCS) are some of the technological processes gaining more focus in recent times. Single-cell analysis and single cell spatial analysis is a rapidly evolving field where individual cells are analyzed for the assessment of changing cell behavior and function over time during its natural states or when perturbed by external factors, it is gaining prominence in the overall cell analysis market because of its extensive application in different research areas.
According to IQ4I analysis, the cell analysis global market is expected to grow at a low single digit CAGR from 2022 to 2029 to reach $38,020.6 million by 2029. The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding towards cell based research, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery processes are driving the cell analysis market. Growing focus on personalized medicine and the introduction of advanced technologies in the cellular analysis process provides immense opportunities to the cell analysis market. However, stringent government regulations, availability of alternative technologies, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth.
The cell analysis market is mainly segmented based on techniques, products, applications, end-users and geography. Based on the techniques, the cell analysis market is segmented into PCR, sequencing, microfluidics and microarrays, spectrometry, microscopy, cytometry, HCS (High content screening), electrophoresis and others. Among these techniques, PCR accounted for the largest revenue in 2022. Sequencing is expected to grow at a double digit CAGR from 2022 to 2029.